Athanor Capital, LP Revolution Medicines, Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$29.0 - $47.44 $235,103 - $384,596	-8,107 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$37.21 - $54.43 $444,473 - $650,166	-11,945 Reduced 59.57%	8,107 $372,000
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $176,762 - $266,343	5,855 Added 41.24%	20,052 $794,000
Q3 2020 Nov 16, 2020	SELL	$22.61 - $34.8 $282,466 - $434,756	-12,493 Reduced 46.81%	14,197 $494,000
Q2 2020 Aug 13, 2020	BUY	$19.65 - $39.34 $524,458 - $1.05 Million	26,690 New	26,690 $843,000

296

168M

920K

1.06M

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.28B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.